To date, fewer than 50 patients with <i>NDUFAF6</i>-related mitochondrial disease have been reported, displaying a broad phenotypic spectrum ranging from early-onset neurodevelopmental regression to milder, more chronic presentations. Here, NDUFAF6 is linked to inborn mitochondrial metabolism disorder.